Mark Yeeles, VP Industrial Automation, Schneider Electric, examines five important areas pharmaceutical facilities need to be aware of to transform their operations and improve production.
Alan Ryan, owner of Technoprint, outlines some of the ways the business makes sure it stays ahead of the game when it comes to sustainability. Alan delves deeper into the topic of leaflets, packaging and sourcing products sustainability.
EPM sat with Marivi Mendizabal, vice president Quality and Regulatory, Cytiva, as she explains how government policy and regulatory trends impact the biopharma industry, and how collaborating with the government can enhance biopharma resilience.
Download this whitepaper and read through Camfil's 10 tips on the most important factors to consider when determining reliable dust collection solutions for tablet press applications.
Chris Allen, CEO of UK-based analytical testing and scientific consultancy provider Broughton, explains the challenges — and opportunities — that Brexit holds for laboratory services.
Mark Arnold, MD of ONFAB, part of Envair Technology, describes the challenges in handling HPAPIs and how pharma manufacturers can learn to manage the risk involved.
Melissa Mooney, director of eCOA Solutions Engineering at IQVIA, explains how successful oncology drug development relies on an accurate depiction of the patient voice, as well as 5 key considerations for developing a patient-centric eCOA strategy.
Michael Earl, director, Pharmaceutical Services at Owen Mumford, explains how Owen Mumford’s Covid-compliant study design and careful planning allowed them to finalise their product design and present this innovative product to the market.
Mark Gregory, chief pharmacy officer for Pleio, focuses on pharmacy services as a component of healthcare delivery, and the power of the human connection in optimising pharmacy’s digital transformation.
Mark Tunkel, global category director, Services at Nemera, explores the factors that should be considered when developing a device strategy in the current technology landscape, and how a holistic approach can lead to better decisions.
Anne-Cecile Bayne, global science & innovation lead Pharma & Medical Nutrition, DSM discusses the benefits of using antioxidants to block nitrosamine development in drug products, and futureproof pharma formulations.
